Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. This article explores the top pharma marketing trends that are set to redefine the landscape in the coming years.

Marketing 52

Marketing Healthcare Healthcare Pharma 52

Pharma Marketing Network

DECEMBER 17, 2021

Big pharma has compelling reasons to change the way business gets done. Increasing competition for talent, as well as the uncertainty of remote versus in-person workspaces, impacts new hire engagement. What is Big Pharma doing to tackle climate change? Health for Humanity 2025 Goals. Our world is in our hands.

Pharma 103

Pharma Ethics Recruitment Government 103

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Pharma is a highly regulated industry and that is often why it is slow to adopt new technologies,” says Kazuki.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

Pharmaceutical Technology

NOVEMBER 22, 2022

China will continue to take steps towards becoming as competitive in high-value innovative pharma as it is in the generics industry, with The Wall Street Journal reporting Chinese biotechs raised $1.6tn through 568 venture financings last year, up from $11bn in 418 deals in 2020.

Manufacturing 64

Manufacturing Pharma Government FDA 64

Clarivate

JANUARY 23, 2024

R&D spend is steadily growing and is expected to reach approximately $200 billion by 2025. To learn more about how Clarivate and CMR International help pharmas future-proof their portfolios, please visit us here. The post Pharma R&D productivity dips, but efficiency gains give hope appeared first on Clarivate.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Pharmaceutical Technology

JULY 21, 2022

Pharma giant AstraZeneca also plans to make its supply chain carbon-negative by 2030; to reduce its Scope 1 emissions by 20%, Scope 2 emissions by 95%, and Scope 3 emissions by 25% per $1m of sales by 2025. In 2020, Fisher & Paykel Healthcare, a medical devices firm, made a SBTi commitment to reduce GHG emissions by 67% by 2034.

Government 52

Government Healthcare Healthcare Pharma 52

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting. The situation was reversed only 25 years ago.

Pharmaceutical 88

Pharmaceutical Manufacturing Medicine Competition 88

PM360

AUGUST 9, 2022

This new world order is marked by smaller, fragmented opportunities, increasing headwinds in high investment therapeutic areas, more complex customer groups requiring nuanced engagement models, and more compressed resources and investment from global pharma. Ask: Is this component truly a competitive advantage? The Payoff Is Real.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

pharmaphorum

JANUARY 4, 2023

It has been proposed that the amount of these fees charged by the data holder must be transparent, proportionate, and “must not restrict competition” 10. The EC is hoping that, by the end of its current mandate on 31 October 2024, the legislative process will be completed, with the EHDS becoming operational in 2025.

Pharmaceutical 82

Pharmaceutical Electronics Healthcare Healthcare 82

Healthcare Success

NOVEMBER 7, 2022

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. For example, pharma marketers can track and attribute increased prescriptions to specific ad campaigns. Your ads should be streaming, too.

Marketing 52

Marketing Media Healthcare Healthcare 52

Celeritas

NOVEMBER 7, 2022

billion by 2025. The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. Automated cleaning systems improve hygiene to lower the risk of infection and facilitate the ease of access for waste removal machinery. The drone services market size is expected to grow to $63.6

Networking 52

Networking Pharmaceutical products Management Transportation 52

Clarivate

OCTOBER 10, 2022

Fruquintinib will face fierce competition should it be approved in the third- and later-line setting. The question of which KRAS inhibitor is most effective remains elusive, although being first to market in addition to strong efficacy and safety data could differentiate the more competitive agent.

Marketing 52

Marketing Safety Patients Competition 52

Pharmaceutical Technology

JANUARY 10, 2023

Last August, CinCor Pharma raised $258.7 We have indicated to investors that we want to be a sustainably growing company, so until 2025 we have strong growth ahead of us, but we also continue to believe that we can grow very strongly past 2025,” said Soriot. the deal with AstraZeneca now signals the company’s growth strategy.

Prospecting 98

Prospecting Pharma Pharmaceutical Competition 98

Pharmaceutical Technology

MAY 30, 2023

An analysis from GlobalData forecasted $3.3bn worth of spending on AI in drug discovery by 2025, more than triple the $1bn spent in 2019, and a year-on-year growth of 24.4%. CEO Mati Gill praised Israel’s impressive pharma landscape and tech industry for enabling these developments.

Pharma 84

Pharma Government Prospecting Education 84

Pharmaceutical Technology

MAY 30, 2023

An analysis from GlobalData forecasted $3.3bn worth of spending on AI in drug discovery by 2025, more than triple the $1bn spent in 2019, and a year-on-year growth of 24.4%. CEO Mati Gill praised Israel’s impressive pharma landscape and tech industry for enabling these developments.

Pharma 52

Pharma Government Prospecting Education 52

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. In highly competitive categories like diabetes, net price could be half of the list price. That compares to the $240.4 billion in spending across all Part D drugs that year (2022) and the $43.6

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Clarivate

OCTOBER 17, 2024

However, recommendations from the Heritage Foundation’s Project 2025 could influence policymaking under a Trump administration. The immediate issue for whoever wins will be expanded subsidies extended by the Inflation Reduction Act, which are set to expire at the end of 2025. Extending them would require Congressional action.

Healthcare 52

Healthcare Healthcare Government Insurance 52